FDA inspection
Chongqing Daxin Pharmaceutical Co., Ltd.: FDA inspection ending Jun 28, 2024
FDA inspection 1245029 · Voluntary Action Indicated (VAI) · Chongqing
Key facts
| Inspection ID | 1245029 |
|---|---|
| Firm | Chongqing Daxin Pharmaceutical Co., Ltd. |
| FEI number | 3000291692 |
| Address | No. 21 Founder Road, Shuituzhen |
| City | Chongqing |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Jun 28, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data